860634P

C16 Dihydroceramide (d18:0/16:0)

Avanti Research^™ - A Croda Brand 860634P, powder

• Synonym(e): N-palmitoyl-D-erythro-sphinganine
• Empirische Formel (Hill-System): C₃₄H₆₉NO₃
• CAS-Nummer: 5966-29-0
• Molekulargewicht: 539.92
• MDL-Nummer: MFCD02094233
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Form: powder
• Verpackung: pkg of 1 × 10 mg (860634P-10mg); pkg of 1 × 5 mg (860634P-5mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 860634P
• Lipid-Typ: sphingolipids
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: OC[C@]([H])(NC(CCCCCCCCCCCCCCC)=O)[C@]([H])(O)CCCCCCCCCCCCCCC
• InChI: 1S/C34H69NO3/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-33(37)32(31-36)35-34(38)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h32-33,36-37H,3-31H2,1-2H3,(H,35,38)/t32-,33+/m0/s1
• InChIKey: GCGTXOVNNFGTPQ-JHOUSYSJSA-N

Beschreibung

Anwendung

C16 Dihydroceramide (d18:0/16:0) is suitable for use to study the potential relevance of the changes observed in the sphingolipid composition of autophagosomes and autolysosomes in tetrahydrocannabinol (THC) treated cells or to destabilize biological membranes.

Biochem./physiol. Wirkung

Dihydroceramide acts as a precursor for ceramide synthesis. It has an ability to induce autophagy in the perinuclear region. Dihydroceramide affects autophagic flux and enhances the formation lipid droplets. Accumulation of C16-dihydroceramides might lead to liver injury.

Verpackung

5 mL Amber Glass Screw Cap Vial (860634P-10mg)

5 mL Amber Glass Screw Cap Vial (860634P-5mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids